AAAAAA

   
Results: 1-16 |
Results: 16
ENHANCED ACTIVITY OF THE CENTRAL ANGIOTENSINERGIC AND VASOPRESSINERGIC SYSTEM IN RENIN TRANSGENIC HYPERTENSION
Authors: SZCZEPANSKASADOWSKA E PACZWA P LON S GANTEN U GANTEN D
Citation: E. Szczepanskasadowska et al., ENHANCED ACTIVITY OF THE CENTRAL ANGIOTENSINERGIC AND VASOPRESSINERGIC SYSTEM IN RENIN TRANSGENIC HYPERTENSION, The FASEB journal, 12(4), 1998, pp. 241-241
DECREASED HYPOTENSIVE RESPONSIVENESS TO NITRIC-OXIDE DONOR S-NITROSO N-ACETYL-DL-PENICILLAMINE (SNAP) IN SPONTANEOUSLY HYPERTENSIVE (SHR) RATS
Authors: STYS T STYS A PACZWA P SZCZEPANSKASADOWSKA E LIPKOWSKI AW
Citation: T. Stys et al., DECREASED HYPOTENSIVE RESPONSIVENESS TO NITRIC-OXIDE DONOR S-NITROSO N-ACETYL-DL-PENICILLAMINE (SNAP) IN SPONTANEOUSLY HYPERTENSIVE (SHR) RATS, Journal of Physiology and Pharmacology, 49(1), 1998, pp. 37-49
ROLE OF CENTRAL NITRIC-OXIDE IN HEMODYNAMIC ADAPTATION TO HYPOVOLEMICAND SODIUM CHALLENGES IN SPONTANEOUSLY HYPERTENSIVE RATS
Authors: PACZWA P SZCZEPANSKASADOWSKA E
Citation: P. Paczwa et E. Szczepanskasadowska, ROLE OF CENTRAL NITRIC-OXIDE IN HEMODYNAMIC ADAPTATION TO HYPOVOLEMICAND SODIUM CHALLENGES IN SPONTANEOUSLY HYPERTENSIVE RATS, Journal of hypertension, 16, 1998, pp. 1257-1257
ROLE OF THE CENTRAL ANGIOTENSIN AT1 RECEPTORS IN BLOOD-PRESSURE REGULATION IN RATS WITH RENIN TRANSGENIC HYPERTENSION
Authors: SZCZEPANSKASADOWSKA E PACZWA P LORI S GANTEN D
Citation: E. Szczepanskasadowska et al., ROLE OF THE CENTRAL ANGIOTENSIN AT1 RECEPTORS IN BLOOD-PRESSURE REGULATION IN RATS WITH RENIN TRANSGENIC HYPERTENSION, Journal of hypertension, 16, 1998, pp. 1635-1635
INCREASED PRESSOR FUNCTION OF CENTRAL VASOPRESSINERGIC SYSTEM IN HYPERTENSIVE RENIN TRANSGENIC RATS
Authors: SZCZEPANSKASADOWSKA E PACZWA P LON S GANTEN D
Citation: E. Szczepanskasadowska et al., INCREASED PRESSOR FUNCTION OF CENTRAL VASOPRESSINERGIC SYSTEM IN HYPERTENSIVE RENIN TRANSGENIC RATS, Journal of hypertension, 16(10), 1998, pp. 1505-1514
EVIDENCE THAT NITRIC-OXIDE REDUCES CENTRAL PRESSOR EFFECT OF AVP IN SHR RATS
Authors: PACZWA P BUDZIKOWSKI A SZCZEPANSKASADOWSKA E
Citation: P. Paczwa et al., EVIDENCE THAT NITRIC-OXIDE REDUCES CENTRAL PRESSOR EFFECT OF AVP IN SHR RATS, Fundamental and clinical pharmacology, 11, 1997, pp. 122-123
BLOCKADE OF CENTRAL V1 AVP RECEPTORS AND NO FORMATION EXERTS DIFFERENTIAL-EFFECTS ON BLOOD-PRESSURE REGULATION DURING HYPOVOLEMIA IN WKY AND SHR RATS
Authors: SZCZEPANSKASADOWSKA E PACZWA P BUDZIKOWSKI A
Citation: E. Szczepanskasadowska et al., BLOCKADE OF CENTRAL V1 AVP RECEPTORS AND NO FORMATION EXERTS DIFFERENTIAL-EFFECTS ON BLOOD-PRESSURE REGULATION DURING HYPOVOLEMIA IN WKY AND SHR RATS, Fundamental and clinical pharmacology, 11, 1997, pp. 133-134
ROLE OF ENDOGENOUS CENTRALLY RELEASED NO IN CARDIOVASCULAR ADAPTATIONTO HYPOVOLEMIA IN WKY AND SHR
Authors: PACZWA P BUDZIKOWSKI AS SZCZEPANSKASADOWSKA E
Citation: P. Paczwa et al., ROLE OF ENDOGENOUS CENTRALLY RELEASED NO IN CARDIOVASCULAR ADAPTATIONTO HYPOVOLEMIA IN WKY AND SHR, American journal of physiology. Heart and circulatory physiology, 41(5), 1997, pp. 2282-2288
ENHANCEMENT OF CENTRAL PRESSOR EFFECT OF AVP IN SHR AND WKY RATS BY INTRACRANIAL N-G-NITRO-L-ARGININE
Authors: PACZWA P BUDZIKOWSKI AS SZCZEPANSKASADOWSKA E
Citation: P. Paczwa et al., ENHANCEMENT OF CENTRAL PRESSOR EFFECT OF AVP IN SHR AND WKY RATS BY INTRACRANIAL N-G-NITRO-L-ARGININE, Brain research, 748(1-2), 1997, pp. 51-61
CENTRAL V-1 AVP RECEPTORS ARE INVOLVED IN CARDIOVASCULAR ADAPTATION TO HYPOVOLEMIA IN WKY BUT NOT IN SHR
Authors: BUDZIKOWSKI AS PACZWA P SZCZEPANSKASADOWSKA E
Citation: As. Budzikowski et al., CENTRAL V-1 AVP RECEPTORS ARE INVOLVED IN CARDIOVASCULAR ADAPTATION TO HYPOVOLEMIA IN WKY BUT NOT IN SHR, American journal of physiology. Heart and circulatory physiology, 40(3), 1996, pp. 1057-1064
EVIDENCE THAT CENTRALLY RELEASED ARGININE-VASOPRESSIN IS INVOLVED IN CENTRAL PRESSOR ACTION OF ANGIOTENSIN-II
Authors: LON S SZCZEPANSKASADOWSKA E SZCZYPACZEWSKA M
Citation: S. Lon et al., EVIDENCE THAT CENTRALLY RELEASED ARGININE-VASOPRESSIN IS INVOLVED IN CENTRAL PRESSOR ACTION OF ANGIOTENSIN-II, American journal of physiology. Heart and circulatory physiology, 39(1), 1996, pp. 167-173
INTERACTION OF VASOPRESSIN AND ANGIOTENSIN-II IN CENTRAL CONTROL OF BLOOD-PRESSURE AND THIRST
Authors: SZCZEPANSKASADOWSKA E
Citation: E. Szczepanskasadowska, INTERACTION OF VASOPRESSIN AND ANGIOTENSIN-II IN CENTRAL CONTROL OF BLOOD-PRESSURE AND THIRST, Regulatory peptides, 66(1-2), 1996, pp. 65-71
PROLONGED STIMULATION OF INTRARENAL V-1 VASOPRESSIN RECEPTORS RESULTSIN SUSTAINED HYPERTENSION
Authors: SZCZEPANSKASADOWSKA E STEPNIAKOWSKI K SKELTON MM COWLEY AW
Citation: E. Szczepanskasadowska et al., PROLONGED STIMULATION OF INTRARENAL V-1 VASOPRESSIN RECEPTORS RESULTSIN SUSTAINED HYPERTENSION, American journal of physiology. Regulatory, integrative and comparative physiology, 36(5), 1994, pp. 1217-1225
CENTRAL CARDIOVASCULAR EFFECTS OF AVP AND ANP IN NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS
Authors: STEPNIAKOWSKI K BUDZIKOWSKI A LON S SZCZEPANSKASADOWSKA E
Citation: K. Stepniakowski et al., CENTRAL CARDIOVASCULAR EFFECTS OF AVP AND ANP IN NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS, Journal of the autonomic nervous system, 47(1-2), 1994, pp. 33-43
CHRONIC INTRAVENOUS ADMINISTRATION OF V-1 ARGININE-VASOPRESSIN AGONIST RESULTS IN SUSTAINED HYPERTENSION
Authors: COWLEY AW SZCZEPANSKASADOWSKA E STEPNIAKOWSKI K MATTSON D
Citation: Aw. Cowley et al., CHRONIC INTRAVENOUS ADMINISTRATION OF V-1 ARGININE-VASOPRESSIN AGONIST RESULTS IN SUSTAINED HYPERTENSION, The American journal of physiology, 267(2), 1994, pp. 80000751-80000756
CENTRAL CARDIOVASCULAR EFFECTS OF AVP AND AVP ANALOGS WITH V(1), V(2)AND V(3) AGONISTIC OR ANTAGONISTIC PROPERTIES IN CONSCIOUS DOG
Authors: NOSZCZYK B LON S SZCZEPANSKASADOWSKA E
Citation: B. Noszczyk et al., CENTRAL CARDIOVASCULAR EFFECTS OF AVP AND AVP ANALOGS WITH V(1), V(2)AND V(3) AGONISTIC OR ANTAGONISTIC PROPERTIES IN CONSCIOUS DOG, Brain research, 610(1), 1993, pp. 115-126
Risultati: 1-16 |